Health TrialsbyHealthPanel

Parkinson Disease Psychosis

3

Review clinical trials related to Parkinson Disease Psychosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

It is hypothesize that patients with clinically diagnosed neurodegenerative diseases will have significantly different receptor occupancy of 5HT2A receptors compared to a healthy age/sex-matched control group. This will be tested by measuring 5HT2A receptor density using the PET radioligand (R)-\[18F\]MH.MZ in both populations.

Participants needed: 75
Trial details
Phase: Phase 4Age: 50-85Biological sex: AllType: InterventionalSponsor: Vanderbilt University Medical CenterUpdated: Aug 7, 2026Locations: 1
Eligibility criteria

Patient arm - clinical diagnosis of Parkinson disease, diffuse Lewy body disease... [+3]

Prior stroke or other uncontrolled serious neurological or medical illness [+8]

Read more
Status: Not yet recruiting

Effect of Food and Age on the Pharmacokinetics of LY03017

This study consists of 2 parts. Part A is a randomized, open-label, 2-period, crossover study to evaluate the food effect of LY03017 in healthy adults. Part B is a single-arm study to evaluate the safety and pharmacokinetics of LY03017 in elderly volunteers.

Participants needed: 26
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Luye Pharma Group Ltd.Updated: Jan 27, 2025Locations: 1
Eligibility criteria

Subject who voluntarily participate and sign the informed consent form. [+4]

Subject has a history of allergy to any component of the investigational drug or... [+24]

Read more
Status: Recruiting

A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics and pharmacodynamics of oral doses of FB418 in healthy adult subjects and healthy elderly subjects.

Participants needed: 64
Trial details
Phase: Phase 1Age: 19+Biological sex: AllType: InterventionalSponsor: 1ST Biotherapeutics, Inc.Updated: Dec 2, 2024Locations: 1
Eligibility criteria

Healthy, adult, male 19 55 years of age, inclusive, at the screening. [+6]

Is mentally or legally incapacitated or has significant emotional problems at th... [+10]

Read more